22 results
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
” and a “smaller reporting company” and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies … and regulations regarding corporate governance practices. The listing requirements of the Nasdaq Global Market and the rules of the SEC require that we
DRS
r4cv8
20 Oct 22
Draft registration statement
12:00am
DEF 14A
dzmnsn37iwvront4w
25 Apr 22
Definitive proxy
5:28pm
10-K
uysli35plw
30 Mar 22
Annual report
7:40am
10-Q
f9ol61yb381mpxi4fvs
17 Nov 21
Quarterly report
5:15pm
8-K
f6yet5r qamh0ex
3 Nov 21
Departure of Directors or Certain Officers
4:25pm
8-K
EX-3.2
vcmosvr8syvp vnp7e
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
vdn9tv7nfemxabh6t09i
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
e3iveyxd idsucku
19 Jul 21
IPO registration
7:02am